Evidence map›Paper›PMID 27532680›Full record

ArticlePloS one2016

Prolonged Exposure of Primary Human Muscle Cells to Plasma Fatty Acids Associated with Obese Phenotype Induces Persistent Suppression of Muscle Mitochondrial ATP Synthase β Subunit.

Lee Tran, Paul D Hanavan, Latoya E Campbell, Elena De Filippis, Douglas F Lake, Dawn K Coletta, Lori R Roust, Lawrence J Mandarino, Chad C Carroll, Christos S Katsanos

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Increased serum levels of S100A1, ZAG, and adiponectin in cachectic patients with COPD.International journal of chronic obstructive pulmonary disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lee TranCenter for Metabolic and Vascular Biology, Arizona State University and Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America.
Paul D HanavanCenter for Metabolic and Vascular Biology, Arizona State University and Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America.
Latoya E CampbellCenter for Metabolic and Vascular Biology, Arizona State University and Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America.
Elena De FilippisDepartment of Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America.
Douglas F LakeCenter for Metabolic and Vascular Biology, Arizona State University and Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America.
Dawn K ColettaCenter for Metabolic and Vascular Biology, Arizona State University and Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America.
Lori R RoustDepartment of Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America.
Lawrence J MandarinoCenter for Metabolic and Vascular Biology, Arizona State University and Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America.
Chad C CarrollDepartment of Physiology, Midwestern University, Glendale, Arizona, United States of America.
Christos S KatsanosCenter for Metabolic and Vascular Biology, Arizona State University and Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America.
Mayo Clinic in Arizona · USArizona State University · USMidwestern University · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
TECHNOLOGY NMR SPECTROSCOPYU24DK100469 · NIDDK · MAYO CLINIC ROCHESTER · PI NAIR, K SREEKUMARAN · 2013 to 2017
$9.0M
Epigenetics and the Origin of Muscle Insulin Resistance in HumansR01DK094013 · NIDDK · UNIVERSITY OF ARIZONA · PI COLETTA, DAWN KATRINA · 2012 to 2016
$1.9M
Regulation of Muscle ATP Synthase Beta Subunit Metabolism in ObesityR01DK094062 · NIDDK · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI KATSANOS, CHRISTOS S · 2012 to 2015
$1.4M
NCATS NIH HHS UL1 TR000135NIDDK NIH HHS R01 DK094013NIDDK NIH HHS R01 DK094062NIDDK NIH HHS U24 DK100469
6 · The paper itself

Abstract

Our previous studies show reduced abundance of the β-subunit of mitochondrial H+-ATP synthase (β-F1-ATPase) in skeletal muscle of obese individuals. The β-F1-ATPase forms the catalytic core of the ATP synthase, and it is critical for ATP production in muscle. The mechanism(s) impairing β-F1-ATPase metabolism in obesity, however, are not completely understood. First, we studied total muscle protein synthesis and the translation efficiency of β-F1-ATPase in obese (BMI, 36±1 kg/m2) and lean (BMI, 22±1 kg/m2) subjects. Both total protein synthesis (0.044±0.006 vs 0.066±0.006%·h-1) and translation efficiency of β-F1-ATPase (0.0031±0.0007 vs 0.0073±0.0004) were lower in muscle from the obese subjects when compared to the lean controls (P<0.05). We then evaluated these same responses in a primary cell culture model, and tested the specific hypothesis that circulating non-esterified fatty acids (NEFA) in obesity play a role in the responses observed in humans. The findings on total protein synthesis and translation efficiency of β-F1-ATPase in primary myotubes cultured from a lean subject, and after exposure to NEFA extracted from serum of an obese subject, were similar to those obtained in humans. Among candidate microRNAs (i.e., non-coding RNAs regulating gene expression), we identified miR-127-5p in preventing the production of β-F1-ATPase. Muscle expression of miR-127-5p negatively correlated with β-F1-ATPase protein translation efficiency in humans (r = - 0.6744; P<0.01), and could be modeled in vitro by prolonged exposure of primary myotubes derived from the lean subject to NEFA extracted from the obese subject. On the other hand, locked nucleic acid inhibitor synthesized to target miR-127-5p significantly increased β-F1-ATPase translation efficiency in myotubes (0.6±0.1 vs 1.3±0.3, in control vs exposure to 50 nM inhibitor; P<0.05). Our experiments implicate circulating NEFA in obesity in suppressing muscle protein metabolism, and establish impaired β-F1-ATPase translation as an important consequence of obesity.

Indexed as

AdultCells, CulturedDietary FatsEpigenesis, GeneticFatty Acids, NonesterifiedFemaleHumansMaleMicroRNAsMitochondrial Proton-Translocating ATPasesMitochondria, MuscleMuscle DevelopmentMuscle Fibers, SkeletalMuscle ProteinsMyoD ProteinMyogeninATP5F1B protein, humanDietary FatsFatty Acids, NonesterifiedMicroRNAsMIRN127 microRNA, humanMitochondrial Proton-Translocating ATPasesMuscle ProteinsMyoD1 myogenic differentiation proteinMyoD ProteinMyogenin

Identifiers

PMID27532680
PMCPMC4988792
OpenAlexW2513081868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.